Cabot Stock of the Month Reviews

"Tim, I am writing to say thank you! You brought my attention to Middleby last July. At that time, I bought in at the share price of 73.59. I sold my shares on Thursday May 14 at 109.72 the recommend minimum sell price that Roy had set. I realized a return of 49% on my money in 9.5 months! I appreciate all the work you and the team does at Cabot. I am thankful to have found your company." Sincerely, J. Cook, Arcadia, California

"Tim, Thank you for your advice. All 3 of your picks are great. BIIB is going to the moon. I bought SLXP this morning. Sold YY last week with some substantial gain. Cabot is the best. My great appreciation to you, Mike and Paul. "—A. S., Laguna Beach, California 

"Hi Mr. Lutts, Thanks for a winner in Stryker (SYK), like others who watch your newsletters I had purchased Stryker on Cabot’s recommendation a while back and last night it hit my sell limit at 81. Nice profit for me and it will pay for more of your newsletters! I have told several friends and hopefully they will become subscribers too. Thanks again for your advice and sharing your knowledge."—Rob Rochelle, Charlotte, North Carolina 

"I am "blown away" by the value I receive from the Cabot group. You offer even more than promised. Kindest regards,"—Sophia Z., Long Island City, New York

"I keep reading your letters with great interest and I want you to count on my respect and my support from now on. I appreciate your letter along with your recommendations. Best regards, Timothy, I look forward to keep doing business with you and your team, a great team I am sure."— A. Cloutier, Quebec, Canada 

"An easy way to invest without any worry."—D. Aston, Florence, Alabama

“This is exactly the kind of information I need. Please keep it up.”—T. Picking, Pueblo, Colorado

"It is your qualities of truthfulness, honesty and candor that have drawn me to the Cabot family of letters and to date, I am very pleased. The yo-yo effect of the market has not phased me. Reading your letters are like a prayer to me...they calm me."—A. Khorsandian, Daytona Beach, Florida

More information on Cabot Stock of the Month
More subscriber comments

Stock Picks

Ross Stores

McKesson (MCK) distributes ethical and proprietary drugs, surgical supplies and health and beauty products throughout North America to the healthcare industry. The company also provides technical consulting services to biotech and pharmaceutical manufacturers.

Carnival Cruise Lines

Having just returned from vacation, Tim Lutts is thinking of the millions of baby-boomers who are spending more and more money on leisure travel, particularly on cruises, an industry that is dominated by a few big players.

China Biologic Products

Paul Goodwin advises putting this stock on your watch list.

Cabot Wealth Advisory

Managing Your Stock Portfolio to the Market's Tune

By Michael Cintolo on July 30, 2015

In today’s Wealth Advisory, I’m doing something I’ve never done before—reprinting an entire piece I wrote in Cabot Growth Investor last Wednesday. It doesn’t involve any specific stock advice (that is and always will be for subscribers only), but it details the wild divergences in the market (which are now getting lots of press—even the Wall Street Journal had a big write-up on it Monday), what it means, and how I’m advising people to handle it—I think it’s very timely.Read More >

Do Your Stocks Have Borrowing Trouble?

By Nancy Zambell on July 28, 2015

Hostess is making news today as it is issuing $1.23 million in term loans—most of which will go toward paying $905 million in a special dividend to its private shareholders—which I may add, is also more than two times what the buyers paid for this tasty snack business, and triples the company’s debt. According to Bloomberg, these types of deals grew to nearly $16 billion in the second quarter, the highest level in the past 12 months. I’m not making a judgment for or against this action. I just want to make a point that this debt, or leverage recapitalization—spurred by low interest rates—is increasingly becoming a method in which private equity holders get their money back—without selling the business. But it does burden the company with additional debt, which isn’t going to fund company expansion or operations.Read More >

Sell Apple

By Timothy Lutts on July 27, 2015

Today, I’m writing on a MacBook Pro. This morning I did my morning crossword puzzle on my iPad. All day long, my iPhone is by my side. My home Wi-Fi comes from Apple AirPorts. And some nights, I stream entertainment through my Apple TV. In short, I love Apple products, and I expect to continue using them for many more years. But one of the most important market truisms is this: “The company is not the stock.”Read More >